The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Biology and management of pancreatic cancer
Open accessAbstract
Pancreatic cancer continues to pose an enormous challenge to clinicians and cancer scientists. With a more affluent world the global incidence of pancreatic cancer is rising. For the first time significant advances are now being made into the management of the disease. There is a more sophisticated approach to palliative care and the centralisation of pancreatic cancer services is leading to greater tumour resection rates. Newer adjuvant modalities are also greatly increasing the 5 year survival rates. The molecular basis of pancreatic cancer is now better understood than ever before, leading to the development of new diagnostic approaches and the introduction of mechanistic based treatments. Technical advances in imaging and great improvements in conventional and molecular pathology have led to a deeper understanding of the pathological variables of the disease. This is now an important time for making big inroads into what still remains the most lethal of the common cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Self-citationHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Tanaka, M., Chari, S., Adsay, V., Carlos Castillo, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2006) · Pancreatology · doi:10.1159/000090023 · Cited by 2,044
TOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“The mutations result in a constitutively activated form of Ras in which the protein is locked in the GTP-bound state, capable of stimulating a multitude of downstream signalling cascades.(12) K-ras mutations are often found in benign lesions of the pancreas as well as in early precursor lesions.”
BackgroundFriends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,489
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Castillo, C. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,480
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
Chen, J. K., Taipale, J., Cooper, M. K., & Beachy, P. A. (2002) · Genes & Development · doi:10.1101/gad.1025302 · Cited by 1,465
Pancreatic Cancer: Adjuvant Combined Radiation and Chemotherapy Following Curative Resection
Kaiser, M. H. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390320023003 · Cited by 1,406
Klinkenbijl, J. H., Jeekel, J., Sahmoud, T., van Pel, R., Couvreur, M. L., Veenhof, C. H., Arnaud, J. P., Gonzalez, D. G., de Wit, L. T., Hennipman, A., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00006 · Cited by 1,286
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
Pancreatic cancer biology and genetics
Bardeesy, N., & DePinho, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc949 · Cited by 1,142
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126
Neoptolemos, J., Dunn, J., Stocken, D., Almond, J., Link, K., Beger, H., Bassi, C., Falconi, M., Pederzoli, P., Dervenis, C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06651-x · Cited by 1,111
Self-citationProgression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Patched acts catalytically to suppress the activity of Smoothened
Taipale, J., Cooper, M. K., Maiti, T., & Beachy, P. A. (2002) · Nature · doi:10.1038/nature00989 · Cited by 794
Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., & Testa, J. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3636 · Cited by 793
Van Cutsem, E., van de Velde, H., Karasek, P., Oettle, H., Vervenne, W. L., Szawlowski, A., Schoffski, P., Post, S., Verslype, C., Neumann, H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.112 · Cited by 786
Gastrointestinal Tumor Study Group (1987) · Cancer · doi:10.1002/1097-0142(19870615)59:12<2006::aid-cncr2820591206>3.0.co;2-b · Cited by 714
Tumor-suppressive pathways in pancreatic carcinoma.
Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693
Pedrazzoli, S., DiCarlo, V., Dionigi, R., Mosca, F., Pederzoli, P., Pasquali, C., Klöppel, G., Dhaene, K., & Michelassi, F. (1998) · Annals of Surgery · doi:10.1097/00000658-199810000-00007 · Cited by 692
Christianity and Democracy: The Global Picture
Berger, P. L. (2004) · Journal of Democracy · doi:10.1353/jod.2004.0022 · Cited by 689
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678
The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction
Incardona, J. P., Gaffield, W., Kapur, R. P., & Roelink, H. (1998) · Development · doi:10.1242/dev.125.18.3553 · Cited by 656
Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K., Cameron, J. L., & Bos, J. L. (1993) · PubMed Central · Cited by 650
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., Sriuranpong, V., Iso, T., Meszoely, I. M., Wolfe, M. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00140-5 · Cited by 643
Neoptolemos, J. P., Stocken, D. D., Dunn, J., Almond, J., Beger, H. G., Pederzoli, P., Bassi, C., Dervenis, C., Fernández‐Cruz, L., LACAINE, F., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200112000-00007 · Cited by 635
Self-citationStudy Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, Takada, T., Amano, H., Yasuda, H., Nimura, Y., Matsushiro, T., Kato, H., Nagakawa, T., & Nakayama, T. (2002) · Cancer · doi:10.1002/cncr.10831 · Cited by 631
Clinical and genetic characteristics of hereditary pancreatitis in Europe
Howes, N., Lerch, M. M., Greenhalf, W., Stocken, D. D., Ellis, I., Simon, P., Truninger, K., Ammann, R., Cavallini, G., Charnley, R. M., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00013-8 · Cited by 623
Self-citationProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Yeo, C. J., Abrams, R. A., Grochow, L. B., Sohn, T. A., Ord, S. E., Hruban, R. H., Zahurak, M. L., Dooley, W. C., Coleman, J., Sauter, P. K., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00018 · Cited by 595
Herrmann, R., Bodoky, G., Ruhstaller, T., Glimelius, B., Bajetta, E., Schüller, J., Saletti, P., Bauer, J., Figer, A., Pestalozzi, B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0886 · Cited by 595
Pancreaticoduodenectomy with vascular resection: margin status and survival duration
Tseng, J. F., Raut, C. P., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Abdalla, E. K., Gomez, H. F., Sun, C. C., Crane, C. H., Wolff, R. A., et al. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.046 · Cited by 557
Bramhall, S. R., Schulz, J., Nemunaitis, J., Brown, P. D., Baillet, M., & Buckels, J. A. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600446 · Cited by 557
Friess, H., Yamanaka, Y., Büchler, M., Ebert, M., Beger, H. G., Gold, L. I., & Korc, M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91084-u · Cited by 522
Wong, G. Y., Schroeder, D. R., Carns, P. E., Wilson, J. L., Martin, D. P., Kinney, M. O., Mantilla, C. B., & Warner, D. O. (2004) · JAMA · doi:10.1001/jama.291.9.1092 · Cited by 506
Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buchier, M., & Beger, H. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116001 · Cited by 492
Farnell, M. B., Pearson, R. K., Sarr, M. G., DiMagno, E. P., Burgart, L. J., Dahl, T. R., Foster, N., Sargent, D. J., & the Pancreas Cancer Working Group (2005) · Surgery · doi:10.1016/j.surg.2005.06.044 · Cited by 482
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
Xiong, H. Q., Rosenberg, A., LoBuglio, A., Schmidt, W., Wolff, R. A., Deutsch, J., Needle, M., & Abbruzzese, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.040 · Cited by 479
Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
Kane, R. C., Farrell, A. T., Saber, H., Tang, S., Williams, G., Jee, J. M., Liang, C., Booth, B., Chidambaram, N., Morse, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1249 · Cited by 474
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Kindler, H. L., Friberg, G., Singh, D. A., Locker, G., Nattam, S., Kozloff, M., Taber, D. A., Karrison, T., Dachman, A., Stadler, W. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9661 · Cited by 460
Risk of pancreatic adenocarcinoma in chronic pancreatitis
Malka, D., Hammel, P., Maire, F., Rufat, P., Madeira, I., Pessione, F., Lévy, P., & Ruszniewski, P. (2002) · Gut · doi:10.1136/gut.51.6.849 · Cited by 457
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., Ali, S. Z., Jagannath, S., Petersen, G. M., Fishman, E. K., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00244-7 · Cited by 448
INK4a/ARF: A multifunctional tumor suppressor locus
Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Self-citationBramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Pancreatic involvement in von Hippel–Lindau disease
Hammel, P. R., Vilgrain, V., Terris, B., Penfornis, A., Sauvanet, A., Correas, J., Chauveau, D., Balian, A., Beigelman, C., O'Toole, D., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.18143 · Cited by 426
Micames, C. G., Jowell, P. S., White, R. R., Paulson, E. K., Nelson, R. C., Morse, M. A., Hurwitz, H. I., Pappas, T. N., Tyler, D. S., & McGrath, K. (2003) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(03)02009-1 · Cited by 424
Sewnath, M. E., Karsten, T. M., Prins, M. H., Rauws, E. J. A., Obertop, H., & Gouma, D. J. (2002) · Annals of Surgery · doi:10.1097/00000658-200207000-00005 · Cited by 419
Su, G. H., Hruban, R. H., Bansal, R. K., Bova, G. S., Tang, D. J., Shekher, M. C., Westerman, A. M., Entius, M. M., Goggins, M., Yeo, C. J., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65440-5 · Cited by 417
Tran, K. T. C., Smeenk, H. G., van Eijck, C. H. J., Kazemier, G., Hop, W. C., Greve, J. W. G., Terpstra, O. T., Zijlstra, J. A., Klinkert, P., & Jeekel, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143248.71964.29 · Cited by 416
Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2239::aid-cncr6>3.0.co;2-v · Cited by 400
Pathology and genetics of tumors of the digestive system
Yajnik, V. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)70019-4 · Cited by 384
Relationship between hospital volume and late survival after pancreaticoduodenectomy
Birkmeyer, J. D., Warshaw, A. L., Finlayson, S. R. G., Grove, M. R., & Tosteson, A. N. A. (1999) · Surgery · doi:10.1016/s0039-6060(99)70152-2 · Cited by 384
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
Yanagisawa, A., Ohtake, K., Ohashi, K., Hori, M., Kitagawa, T., Sugano, H., & Kato, Y. (1993) · PubMed · Cited by 354
The cancer stem cell hypothesis: a work in progress
Tan, B. T., Park, C. Y., Ailles, L. E., & Weissman, I. L. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700488 · Cited by 348
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings
Hishinuma, S., Ogata, Y., Tomikawa, M., Ozawa, I., Hirabayashi, K., & Igarashi, S. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.016 · Cited by 344
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
Bakkevold, K. E., Arnesjø, B., Dahl, O., & Kambestad, B. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80349-1 · Cited by 338
Ruggeri, B. A., Huang, L., Wood, M., Cheng, J. Q., & Testa, J. R. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199802)21:2<81::aid-mc1>3.3.co;2-k · Cited by 329
Agarwal, B., Abu-Hamda, E., Molke, K. L., Correa, A. M., & Ho, L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04177.x · Cited by 328
Neoptolemos, J. P., Russell, R. C. G., Bramhall, S., & Theis, B. (1997) · British Journal of Surgery · doi:10.1002/bjs.1800841010 · Cited by 327
Self-citationCurrent standards of surgery for pancreatic cancer
Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004) · British Journal of Surgery · doi:10.1002/bjs.4794 · Cited by 321
Self-citationStromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 317
Butturini, G. (2008) · Archives of Surgery · doi:10.1001/archsurg.2007.17 · Cited by 309
Bernhardt, S. L., Gjertsen, M. K., Trachsel, S., Møller, M., Eriksen, J. A., Meo, M., Buanes, T., & Gaudernack, G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603437 · Cited by 305
Precursors to Invasive Pancreatic Cancer
Maitra, A., Fukushima, N., Takaori, K., & Hruban, R. H. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155055.14238.25 · Cited by 291
Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., & Omata, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536861 · Cited by 288
Raut, C. P., Grau, A. M., Staerkel, G. A., Kaw, M., Tamm, E. P., Wolff, R. A., Vauthey, J.-N., Lee, J. E., Pisters, P. W. T., & Evans, D. B. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00150-6 · Cited by 276
Predictors of pancreatic cancer mortality among a large cohort of United States adults
Coughlin, S. S., Calle, E. E., Patel, A. V., & Thun, M. J. (2000) · Cancer Causes & Control · doi:10.1023/a:1026580131793 · Cited by 275
DeWitt, J., Devereaux, B. M., Lehman, G. A., Sherman, S., & Imperiale, T. F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.020 · Cited by 267
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Schwarte-Waldhoff, I., Volpert, O. V., Bouck, N. P., Sipos, B., Hahn, S. A., Klein-Scory, S., Lüttges, J., Klöppel, G., Graeven, U., Eilert-Micus, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9624 · Cited by 266
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?
Salvia, R., Crippa, S., Falconi, M., Bassi, C., Guarise, A., Scarpa, A., & Pederzoli, P. (2007) · Gut · doi:10.1136/gut.2006.100628 · Cited by 263
Picozzi, V. J., Kozarek, R. A., & Traverso, L. W. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00051-5 · Cited by 262
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
Schlieman, M. G., Fahy, B. N., Ramsamooj, R., Beckett, L., & Bold, R. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601396 · Cited by 260
Seiler, C. A., Wagner, M., Bachmann, T., Redaelli, C. A., Schmied, B., Uhl, W., Friess, H., & Büchler, M. W. (2005) · British Journal of Surgery · doi:10.1002/bjs.4881 · Cited by 255
Prasad, N. B., Biankin, A. V., Fukushima, N., Maitra, A., Dhara, S., Elkahloun, A. G., Hruban, R. H., Goggins, M., & Leach, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1413 · Cited by 242
Lévy, P., Jouannaud, V., O’Toole, D., Couvelard, A., Vullierme, M. P., Palazzo, L., Aubert, A., Ponsot, P., Sauvanet, A., Maire, F., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.01.018 · Cited by 240
Sultana, A., Tudur Smith, C., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., & Ghaneh, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603719 · Cited by 235
Self-citationKindler, H. L., Niedzwiecki, D., Hollis, D., Oraefo, E., Schrag, D., Hurwitz, H., McLeod, H. L., Mulcahy, M. F., Schilsky, R. L., & Goldberg, R. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4508 · Cited by 235
Muscari, F., Suc, B., Kirzin, S., Hay, J.-M., Fourtanier, G., Fingerhut, A., Sastre, B., Chipponi, J., Fagniez, P.-L., & Radovanovic, A. (2006) · Surgery · doi:10.1016/j.surg.2005.08.012 · Cited by 233
Lal, G., Liu, G., Schmocker, B., Kaurah, P., Özçelik, H., Narod, S. A., Redston, M. S., & Gallinger, S. (2000) · PubMed · Cited by 231
Riall, T. S., Cameron, J. L., Lillemoe, K. D., Campbell, K. A., Sauter, P. K., Coleman, J., Abrams, R. A., Laheru, D., Hruban, R. H., & Yeo, C. J. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.08.034 · Cited by 219
Meat and Fat Intake as Risk Factors for Pancreatic Cancer: The Multiethnic Cohort Study
Nöthlings, U., Wilkens, L. R., Murphy, S. P., Hankin, J. H., Henderson, B. E., & Kolonel, L. N. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji292 · Cited by 218
Overexpression of HER2/neu oncogene in human pancreatic carcinoma
Yamanaka, Y., Friess, H., Kobrin, M. S., Büchler, M., Kunz, J., Beger, H. G., & Korc, M. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90194-l · Cited by 215
Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism
Pogue-Geile, K. L., Chen, R., Bronner, M. P., Crnogorac-Jurcevic, T., Moyes, K. W., Dowen, S., Otey, C. A., Crispin, D. A., George, R. D., Whitcomb, D. C., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030516 · Cited by 215
Zhao, J., Simeone, D. M., Heidt, D., Anderson, M. A., & Lubman, D. M. (2006) · Journal of Proteome Research · doi:10.1021/pr060034r · Cited by 214
Koopmann, J., Rosenzweig, C. N. W., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., & Goggins, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0564 · Cited by 213
Grewe, M., Gansauge, F., Schmid, R. M., Adler, G., & Seufferlein, T. T. W. (1999) · PubMed · Cited by 209
Pancreatic Cancer in Patients With Pancreatic Cystic Lesions: A Prospective Study in 197 Patients
Tada, M., Kawabe, T., Arizumi, M., Togawa, O., Matsubara, S., Yamamoto, N., Nakai, Y., Sasahira, N., Hirano, K., Tsujino, T., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.07.013 · Cited by 206
Immunotherapy for pancreatic cancer — science driving clinical progress
Laheru, D., & Jaffee, E. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1630 · Cited by 202
Jones, L. E., Humphreys, M. J., Campbell, F., Neoptolemos, J. P., & Boyd, M. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1157-03 · Cited by 200
Self-citationRetinoblastoma: a prototypic hereditary neoplasm.
Knudson, A. G. (1978) · PubMed · Cited by 199
Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma
Koopmann, J., Fedarko, N. S., Jain, A., Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Hruban, R. H., Yeo, C. J., & Goggins, M. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.487.13.3 · Cited by 195
Intraductal Papillary Mucinous Neoplasms of the Pancreas
(2010) · High-Yield Imaging: Gastrointestinal · doi:10.1016/b978-1-4160-5544-0.00190-2 · Cited by 191
Roche, C. J., Hughes, M. L., Garvey, C. J., Campbell, F., White, D. A., Jones, L., & Neoptolemos, J. P. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.2.1800475 · Cited by 184
Self-citationMaire, F., Hammel, P., Ponsot, P., Aubert, A., O'Toole, D., Hentic, O., Levy, P., & Ruszniewski, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00559.x · Cited by 181
Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176
Clinical implications of the mechanism of epidermal growth factor receptor inhibitors
Marshall, J. (2006) · Cancer · doi:10.1002/cncr.22133 · Cited by 175
Frequent activation of AKT2 kinase in human pancreatic carcinomas
Altomare, D. A., Tanno, S., De Rienzo, A., Klein‐Szanto, A. J., Tanno, S., Skele, K. L., Hoffman, J. P., & Testa, J. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10287 · Cited by 174
Ziske, C., Schlie, C., Gorschlüter, M., Glasmacher, A., Mey, U., Strehl, J., Sauerbruch, T., & Schmidt-Wolf, I. G. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601263 · Cited by 167
Ko, A. H., Hwang, J., Venook, A. P., Abbruzzese, J. L., Bergsland, E. K., & Tempero, M. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602687 · Cited by 165
Koomen, J. M., Shih, L. N., Coombes, K. R., Li, D., Xiao, L.-C., Fidler, I. J., Abbruzzese, J. L., & Kobayashi, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1110.11.3 · Cited by 165
Analysis of Long-term Survivors After Surgical Resection for Pancreatic Cancer
Han, S.-S., Jang, J.-Y., Kim, S.-W., Kim, W.-H., Lee, K. U., & Park, Y.-H. (2006) · Pancreas · doi:10.1097/01.mpa.0000202953.87740.93 · Cited by 162
Connor, S. J., Alexakis, N., Garden, O. J., Leandros, E., Bramis, J., & Wigmore, S. J. (2005) · British journal of surgery · doi:10.1002/bjs.5107 · Cited by 155
Adjuvant therapy in pancreatic cancer: historical and current perspectives
Neoptolemos, J. P., Cunningham, D., Frieß, H., Bassi, C., Stocken, D. D., Tait, D., Dunn, J., Dervenis, C., LACAINE, F., Hickey, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg207 · Cited by 149
Self-citationDuell, E. J., Holly, E. A., Bracci, P. M., Liu, M., Wiencke, J. K., & Kelsey, K. T. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.297 · Cited by 148
Possible Detection of Pancreatic Cancer by Plasma Protein Profiling
Honda, K., Hayashida, Y., Umaki, T., Okusaka, T., Kosuge, T., Kikuchi, S., Endo, M., Tsuchida, A., Aoki, T., Itoi, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1851 · Cited by 146
Lüttges, J., Schlehe, B., Menke, M. A. O. H., Vogel, I., Henne‐Bruns, D., & Klöppel, G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1703::aid-cncr9>3.3.co;2-i · Cited by 145
Riall, T. S., Lillemoe, K. D., Cameron, J. L., Huang, J. J., Pitt, H. A., & Yeo, C. J. (1999) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(99)00049-6 · Cited by 144
Ockenga, J., Vogel, A., Teich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00294-4 · Cited by 142
Folate Intake and Pancreatic Cancer Incidence: A Prospective Study of Swedish Women and Men
Larsson, S. C., Håkansson, N., Giovannucci, E. L., & Wolk, A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj094 · Cited by 141
Anticipation in familial pancreatic cancer
McFaul, C. D., Greenhalf, W., Earl, J., Howes, N., Neoptolemos, J. P., Kress, R., Sina-Frey, M., Rieder, H., Hahn, S., & Bartsch, D. K. (2006) · Gut · doi:10.1136/gut.2005.065045 · Cited by 132
Self-citationA New Susceptibility Locus for Autosomal Dominant Pancreatic Cancer Maps to Chromosome 4q32-34
Eberle, M. A., Pfützer, R. H., Pogue-Geile, K. L., Bronner, M. P., Crispin, D. A., Kimmey, M. B., Duerr, R. H., Kruglyak, L., Whitcomb, D. C., & Brentnall, T. A. (2002) · The American Journal of Human Genetics · doi:10.1086/339692 · Cited by 132
Evidence for a major gene influencing risk of pancreatic cancer
Klein, A. P., Beaty, T. H., Wilson, J., Brune, K. A., Hruban, R. H., & Petersen, G. M. (2002) · Genetic Epidemiology · doi:10.1002/gepi.1102 · Cited by 130
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 122
Efficacy of Neurolytic Celiac Plexus Block in Varying Locations of Pancreatic Cancer
Rykowski, J. J., & Hilgier, M. (2000) · Anesthesiology · doi:10.1097/00000542-200002000-00014 · Cited by 121
Lemke, A., Niehues, S. M., Hosten, N., Amthauer, H., Böhmig, M., Stroszczynski, C., Torsten Rohlfing, B., Rosewicz, S., & Felix, R. (2004) · PubMed · Cited by 118
Notch signaling in the regulation of tumor angiogenesis
Rehman, A. O., & Wang, C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.003 · Cited by 118
Molecular Analysis to Detect Pancreatic Ductal Adenocarcinoma in High-Risk Groups
Yan, L., McFaul, C., Howes, N., Leslie, J., Lancaster, G., Wong, T., Threadgold, J., Evans, J. E., Gilmore, I. T., Smart, H. L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.006 · Cited by 117
Self-citationIto, D., Fujimoto, K., Mori, T., Kami, K., Koizumi, M., Toyoda, E., Kawaguchi, Y., & Doi, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21532 · Cited by 117
Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer
Kayed, H., Kleeff, J. H., Keleg, S., Guo, J., Ketterer, K., Berberat, P. O., Giese, N. A., Esposito, I., Giese, T., Büchler, M. W., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20194 · Cited by 113
Catalano, C., Laghi, A., Fraioli, F., Pediconi, F., Napoli, A., Danti, M., Reitano, I., & Passariello, R. (2003) · European Radiology · doi:10.1007/s00330-002-1473-4 · Cited by 108
Duda, D. G., Sunamura, M., Lefter, L. P., Furukawa, T., Yokoyama, T., Yatsuoka, T., Abe, T., Inoue, H., Motoi, F., Egawa, S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206751 · Cited by 107
Management of Intraductal Papillary-mucinous Neoplasm of the Pancreas
Serikawa, M., Sasaki, T., Fujimoto, Y., Kuwahara, K., & Chayama, K. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225609.63975.6f · Cited by 97
A review of erlotinib and its clinical use
Tang, P. A., Tsao, M., & Moore, M. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.2.177 · Cited by 96
Hess, V., Salzberg, M. O., Borner, M., Morant, R., Roth, A. D., Ludwig, C., & Herrmann, R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.029 · Cited by 95
Transforming growth factor-β pathway: Role in pancreas development and pancreatic disease
Rane, S. G., Lee, J., & LIN, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.003 · Cited by 91
Growth factors and their receptors in pancreatic cancer
Ozawa, F., Frieß, H., Tempia‐Caliera, A. A., Kleeff, J. H., & B�chler, M. W. (2000) · Teratogenesis Carcinogenesis and Mutagenesis · Cited by 89
Kosugi, C., Furuse, J., Ishii, H., Maru, Y., Yoshino, M., Kinoshitá, T., Konishi, M., Nakagohri, T., Inoue, K., & Oda, T. (2003) · World Journal of Surgery · doi:10.1007/s00268-003-7003-y · Cited by 89
Molecular targeting therapy for pancreatic cancer
Xiong, H. Q. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0890-2 · Cited by 89
Takehara, A., Eguchi, H., Ohigashi, H., Ishikawa, O., Kasugai, T., Hosokawa, M., Katagiri, T., Nakamura, Y., & Nakagawa, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00297.x · Cited by 83
Choi, M. G. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.1.51 · Cited by 83
Pancreatic cancer: a review of recent advances
Eckel, F., Schneider, G., & Schmid, R. M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.11.1395 · Cited by 83
The Genetics ofFANCCandFANCGin Familial Pancreatic Cancer
Rogers, C. D., van der Heijden, M. S., Brune, K. A., Yeo, C. J., Hruban, R. H., Kern, S. E., & Goggins, M. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.609 · Cited by 82
Pancreatic Cancer Cell Radiation Survival and Prenyltransferase Inhibition: The Role of K-Ras
Brunner, T. B., Cengel, K. A., Hahn, S. M., Wu, J., Fraker, D. L., McKenna, W. G., & Bernhard, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0158 · Cited by 79
BANVILLE, N., GERAGHTY, R., Fox, E., LEAHY, D., Green, A., Keegan, D., Geoghegan, J., OʼDonoghue, D. P., Hyland, J. C., & Sheahan, K. D. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.06.024 · Cited by 78
Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis
Howes, N., & Neoptolemos, J. P. (2002) · Gut · doi:10.1136/gut.51.6.765 · Cited by 74
Self-citationThe rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.
Asano, T., Yao, Y.-X., Zhu, J.-J., Li, D.-H., Abbruzzese, J., & Reddy, S. A. (2005) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2005.03.166 · Cited by 74
Cho, S. G., Lee, D. H., Lee, K. Y., Ji, H., Lee, K. H., Ros, P. R., & Suh, C. H. (2005) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000153956.33296.b5 · Cited by 73
Peutz–Jeghers syndrome and screening for pancreatic cancer
Latchford, A. R., Greenhalf, W., Vitone, L. J., Neoptolemos, J. P., Lancaster, G., & Phillips, R. K. S. (2006) · British journal of surgery · doi:10.1002/bjs.5609 · Cited by 72
Self-citationHedgehog Signaling in the Normal and Diseased Pancreas
Kayed, H., Kleeff, J. H., Osman, T., Keleg, S., Büchler, M. W., & Friess, H. (2006) · Pancreas · doi:10.1097/01.mpa.0000202937.55460.0c · Cited by 70
Lytras, D., Connor, S. J., Bosonnet, L., Jayan, R., Evans, J., Hughes, M., Garvey, C. J., Ghaneh, P., Sutton, R., Vinjamuri, S., et al. (2005) · Digestive Surgery · doi:10.1159/000085347 · Cited by 69
Self-citationChemotherapy for pancreatic cancer
Shore, S., Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2003.01781.x · Cited by 69
Self-citationASCO 2020 Gastrointestinal Cancers Symposium
Pinion, S. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30045-5 · Cited by 69
Bassi, C., Stocken, D. D., Oláh, A., et al. (2005) · Digestive Surgery · doi:10.1159/000089771 · Cited by 68
Bartsch, H., MALAVEILLE, C., Lowenfels, A. B., Maisonneuve, P., Hautefeuille, A. H., & Boyle, P. (1998) · European Journal of Cancer Prevention · doi:10.1097/00008469-199806000-00006 · Cited by 68
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma
Minniti, S., Bruno, C., Biasiutti, C., Tonel, D., Falzone, A., Falconi, M., & Procacci, C. (2003) · Journal of Clinical Ultrasound · doi:10.1002/jcu.10156 · Cited by 68
Connor, S. J., Bosonnet, L., Ghaneh, P., Alexakis, N., Hartley, M., Campbell, F., Sutton, R., & Neoptolemos, J. P. (2004) · British journal of surgery · doi:10.1002/bjs.4761 · Cited by 66
Self-citationMcWilliams, R. R., Highsmith, W. E., Rabe, K. G., de Andrade, M., Tordsen, L. A., Holtegaard, L. M., & Petersen, G. M. (2005) · Gut · doi:10.1136/gut.2005.074534 · Cited by 64
Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
Slater, E. P., Amrillaeva, V., Fendrich, V., Bartsch, D. K., Earl, J., Vitone, L. J., Neoptolemos, J. P., & Greenhalf, W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040164 · Cited by 64
Self-citationA Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
Ryan, D. P., O’Neil, B. H., Supko, J. G., Lima, C. M. R., Dees, E. C., Appleman, L. J., Clark, J. W., Fidias, P., Orlowski, R. Z., Kashala, O., et al. (2006) · Cancer · doi:10.1002/cncr.22280 · Cited by 63
Standard Kausch-Whipple Pancreatoduodenectomy
Jones, L., Russell, C., Mosca, F., Boggi, U., Sutton, R., Slavin, J. P., Hartley, M., & Neoptolemos, J. P. (1999) · Digestive Surgery · doi:10.1159/000018739 · Cited by 53
Self-citationRNASEL germline variants are associated with pancreatic cancer
Bartsch, D. K., Fendrich, V., Slater, E. P., Sina‐Frey, M., Rieder, H., Greenhalf, W., Chaloupka, B., Hahn, S. A., Neoptolemos, J. P., & Kress, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21254 · Cited by 52
Self-citationThe inherited genetics of pancreatic cancer and prospects for secondary screening
Vitone, L. J., Greenhalf, W., McFaul, C., Ghaneh, P., & Neoptolemos, J. P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.007 · Cited by 51
Self-citationWallace, J. A., Locker, G. Y., Nattam, S. R., Kasza, K., Wade-Oliver, K. T., Stadler, W. M., Vokes, E. E., & Kindler, H. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4608 · Cited by 51
Evaluation of the 4q32-34 Locus in European Familial Pancreatic Cancer
Earl, J., Yan, L., Vitone, L. J., Risk, J. M., Kemp, S. J., McFaul, C., Neoptolemos, J. P., Greenhalf, W., for the European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer, Kress, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0376 · Cited by 50
Self-citationPhoa, S. S. K. S., Tilleman, E. H. B. M., van Delden, O. M., Bossuyt, P. M., Gouma, D. J., & Laméris, J. S. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20270 · Cited by 45
Larsson, S. C., Giovannucci, E. L., & Wolk, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.017 · Cited by 45
Specialized DNA Arrays for the Differentiation of Pancreatic Tumors
Buchholz, M., Kestler, H. A., Bauer, A. S., Böck, W., Rau, B., Leder, G. H., Kratzer, W., Bommer, M., Scarpa, A., Schilling, M. K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1274 · Cited by 44
Epithelial differentiation in pancreatic development and neoplasia: new niches for nestin and Notch.
Leach, S. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155547.83901.a3 · Cited by 43
Takahashi, H., Nakamori, S., Nakahira, S., Tsujie, M., Takahshi, Y., Marubashi, S., Miyamoto, A., Takeda, Y., Nagano, H., Dono, K., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.043 · Cited by 41
Review article: chemotherapy for pancreatic cancer
Hore, S., & Eoptolemos, J. P. N. (2003) · Cited by 41
No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma
Grützmann, R., McFaul, C., Bartsch, D. K., Sina-Frey, M., Rieder, H., Koch, R., McCarthy, E., Greenhalf, W., Neoptolemos, J. P., Saeger, H. D., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.012 · Cited by 23
Self-citationIncreasing survival rates of patients with pancreatic cancer by earlier identification
Greenhalf, W., & Neoptolemos, J. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0483 · Cited by 17
Self-citationWhen developmental signaling pathways go wrong and their impact on pancreatic cancer development
Lomberk, G. A., Fernández-Zapico, M. E., & Urrutia, R. A. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000175462.38153.f7 · Cited by 8
Cystic pancreatic neoplasms: 12-year surgical experience.
Carboni, F., Lepiane, P., Santoro, R., Lorusso, R., Mancini, R., Proposito, D., Spoletini, D., & Santoro, E. (2006) · PubMed · Cited by 8
Molecular pathways of pancreatic carcinogenesis
Fernández-Zapico, M. E., & Urrutia, R. A. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.003 · Cited by 4
Ghaneh, P., Magee, C. J., & Neoptolemos, J. P. (2003) · Evidence-based Oncology · doi:10.1002/9780470987360.ch25 · Cited by 4
Self-citation
Research works printed but not linked: 45
- Ko, 2005, Systemic therapy for pancreatic cancer, Semin Radiat Oncol, 15, 245, 10.1016/j.semradonc.2005.06.001 · doi:10.1016/j.semradonc.2005.06.001
- Friess, 1995, Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression, Clin Cancer Res, 1, 1413
- Barton, 1991, Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer, J Pathol, 163, 111, 10.1002/path.1711630206 · doi:10.1002/path.1711630206
- Anonymous, 2004, SWOG S0502: phase lll randomized study of gemcitabine with versus without cetuximab as first-line therapy in patients with locally advanced unresectable or metastatic adenocorcinoma of the pancreas, Clin Adv Hematol Oncol, 2, 201
- de Jonge, 2006, Multiple targeted tyrosine kinase inhibition in the clinic: all for one or one for all?, Eur J Cancer, 42, 1351, 10.1016/j.ejca.2006.02.013 · doi:10.1016/j.ejca.2006.02.013
- Zapatka, 2007, Basement membrane component laminin-5 is a target of the tumor suppressor Smad4, Oncogene, 25, 1417, 10.1038/sj.onc.1209918 · doi:10.1038/sj.onc.1209918
- Narita, 1984, Ataxia-telangiectasia with dysgerminoma of right ovary, papillary carcinoma of thyroid, and adenocarcinoma of pancreas, Cancer, 54, 1113, 10.1002/1097-0142(19840915)54:6<1113::AID-CNCR2820540632>3.0.CO;2-C · doi:10.1002/1097-0142(19840915)54:6<1113::aid-cncr2820540632>3.0.co;2-c
- Seket, 2003, Pancreatic acinar cell carcinoma in a patient with familial adenomatous polyposis, Gastroenterol Clin Biol, 27, 818
- Sudo, 2005, Development of an introductal papillary-mucinous neoplasm of the pancreas in a patient with familial adenomatous polyposis, Pancreas, 31, 428, 10.1097/01.mpa.0000183378.04295.27 · doi:10.1097/01.mpa.0000183378.04295.27
- Klöppel, 1996, World Health Organization international histological typing of tumors of the exocrine pancreas, 1
- Holen, 2002, Clinical characteristics and outcomes from on institutional series of acinar cell carcinoma of the pancreas and related tumors, J Clin Oncol, 20, 4673, 10.1200/JCO.2002.02.005 · doi:10.1200/jco.2002.02.005
- Seo, 2006, Solid-pseudopapillary tumor of the pancreas, J Clin Gastroenterol, 40, 919, 10.1097/01.mcg.0000225671.91722.10 · doi:10.1097/01.mcg.0000225671.91722.10
- Dhebri, 2004, Diagnosis, treatment and outcome of pancreatoblastoma, Pancreatology, 4, 441, 10.1159/000079823 · doi:10.1159/000079823
- Royal College of Pathologists, 2002, Standards and minimum datasets for reporting cancers. Minimum dataset for histopathological reporting of pancreatic, ampulla of vater and bile duct carcinoma
- Neoptolemos, 2005, Is endoscopic ultrasonography superior to multidetector CT for assessing pancreatic cancer?, Nat Clin Pract Oncol, 2, 78, 10.1038/ncponc0096 · doi:10.1038/ncponc0096
- Louhimo, 2004, Serum HCG beta and CA 72–4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer, Oncology, 66, 126, 10.1159/000077438 · doi:10.1159/000077438
- Ozkan, 2006, Significance of serum receptor-binding cancer antigen (RCAS) in pancreatic cancer and benign pancreatobiliaty diseases, Pancreatology, 6, 268, 10.1159/000092687 · doi:10.1159/000092687
- Hanninen, 2005, Magnetic resonance cholangiopancreatography: image quality, ductal morphology, and value of additional T2-and T1-weighted sequences for the assessment of suspected pancreatic cancer, Acta Radiol, 46, 117, 10.1080/02841850510020941 · doi:10.1080/02841850510020941
- Hanninen, 2002, Prospective evaluation of pancreatic tumours: accuracy of MR imaging with MR cholangiopancreotography and MR angiography, Radiology, 224, 34, 10.1148/radiol.2241010798 · doi:10.1148/radiol.2241010798
- Wittmann, 2006, Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study, Cytopathology, 17, 27, 10.1111/j.1365-2303.2006.00313.x · doi:10.1111/j.1365-2303.2006.00313.x
- Doran, 2004, Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours, Dig Surg, 21, 305, 10.1159/000080885 · doi:10.1159/000080885
- Connor, 2005, Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy, Dig Surg, 22, 80, 10.1159/000085297 · doi:10.1159/000085297
- Eguchi, 2006, Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development, Surgery, 139, 749, 10.1016/j.surg.2005.11.008 · doi:10.1016/j.surg.2005.11.008
- Suleyman Ozyalcin, 2004, Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain, Eur J Pain, 8, 539, 10.1016/j.ejpain.2004.01.001 · doi:10.1016/j.ejpain.2004.01.001
- Leksowski, 2001, Thoracoscopic splanchnicectomy for control of intractable pain due to advanced pancreatic cancer, Surg Endosc, 15, 129, 10.1007/s004640090009 · doi:10.1007/s004640090009
- Bruno, 1998, Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region, Gut, 42, 92, 10.1136/gut.42.1.92 · doi:10.1136/gut.42.1.92
- Prat, 1998, Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline, Gut, 42, 76, 10.1136/gut.42.1.76 · doi:10.1136/gut.42.1.76
- Kuriansky, 2000, Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas, Surg Endosc, 14, 179, 10.1007/s004649900095 · doi:10.1007/s004649900095
- Cunningham, 2005, Phase lll randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer, Eur J Cancer, 3, (Suppl
- Smith, 2006, Capecitabine in carcinoma of the pancreas, Expert Opin Pharmacother, 7, 1633, 10.1517/14656566.7.12.1633 · doi:10.1517/14656566.7.12.1633
- Chauffert, 2006, Phase III trial comparing initial chemorodiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: a FFCD-SFRO study, J Clin Oncol, 4008, 10.1200/jco.2006.24.18_suppl.4008 · doi:10.1200/jco.2006.24.18_suppl.4008
- Genentech, Phase III study of Avastin in odvanced pancreatic cancer does not meet primary endpoint
- Roche, Clinical trial protocol registry and results database
- National Cancer Institute, GV1001 and gemcitabine in sequential combination to gemcitabine monotherapy in pancreatic cancer
- National Cancer Institute, Phase III randomized study of chemoimmunotherapy comprising gemcitabine hydrochloride and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer
- Settmacher, 2004, Reconstruction of visceral orteries with homografts in excision of the pancreas, Chirurg, 75, 1199, 10.1007/s00104-004-0899-4 · doi:10.1007/s00104-004-0899-4
- Saleh, 2002, Preoperative endoscopic stent placement before pancreaticoduodenectomy: a meta-analysis of the effect on morbidity and mortality, Gastrointest Endosc, 56, 529, 10.1016/S0016-5107(02)70438-0 · doi:10.1016/s0016-5107(02)70438-0
- Imamura, 2004, A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer, Surgery, 136, 1003, 10.1016/j.surg.2004.04.030 · doi:10.1016/j.surg.2004.04.030
- McKay, 2006, Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy, Br J Surg, 93, 929, 10.1002/bjs.5407 · doi:10.1002/bjs.5407
- Winter, 2006, Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial, J Gastrointest Surg, 10, 1280, 10.1016/j.gassur.2006.07.020 · doi:10.1016/j.gassur.2006.07.020
- Lin, 1999, Prospective randomized comparison between pylorus-preserving and standard pancreatoduodenectomy, Br J Surg, 86, 603, 10.1046/j.1365-2168.1999.01074.x · doi:10.1046/j.1365-2168.1999.01074.x
- Takada, 2002, Is postoperative adjuvant chemotherapy useful for gall-bladder carcinoma?, Cancer, 95, 1685
- Kosuge, 2006, A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer, Jpn J Clin Oncol, 36, 159, 10.1093/jjco/hyi234 · doi:10.1093/jjco/hyi234
- Stocken, 2005, Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer, Br J Cancer, 92, 1372, 10.1038/sj.bjc.6602513 · doi:10.1038/sj.bjc.6602513
- Regine, 2006, RichRTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma, J Clin Oncol, 4007, 10.1200/jco.2006.24.18_suppl.4007 · doi:10.1200/jco.2006.24.18_suppl.4007
Cited by
Huang, L., Holtzinger, A., Jagan, I., BeGora, M., Lohse, I., Ngai, N., Nostro, C., Wang, R., Muthuswamy, L. B., Crawford, H. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3973 · Cited by 740
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
Sarantis, P., Koustas, E., Papadimitropoulou, A., Papavassiliou, A. G., & Karamouzis, M. V. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i2.173 · Cited by 472
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2017) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436
Mazur, P. K., Herner, A., Mello, S. S., Wirth, M., Hausmann, S., Sánchez-Rivera, F. J., Lofgren, S. M., Kuschma, T., Hahn, S. A., Vangala, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3952 · Cited by 397
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Duffy, M. J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V. L., Klapdor, R., Nicolini, A., Topolcan, O., & Heinemann, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp332 · Cited by 381
Metadata
- Authors
- Ghaneh, P., Costello, E., & Neoptolemos, J. P.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-01
- Volume
- 84
- Issue
- 995
- Pages
- 478-497
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2133667676
- Cited by
- 418
- References
- 195
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.